Global Magnetic Resonance Imaging (MRI) Systems Sales Market Report 2021
Magnetic resonance imaging is a kind of tomography, which USES magnetic resonance to obtain electromagnetic signals from the human body and reconstruct human information.
In 2017, Asia Pacific is estimated to account for the largest share of the MRI systems market, followed by Europe.
Market Analysis and Insights: Global Magnetic Resonance Imaging (MRI) Systems Market
The global Magnetic Resonance Imaging (MRI) Systems market was valued at US$ 4957.7 in 2020 and will reach US$ 5954.3 million by the end of 2027, growing at a CAGR of 3.1% during 2022-2027.
Global Magnetic Resonance Imaging (MRI) Systems Scope and Market Size
The global Magnetic Resonance Imaging (MRI) Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Magnetic Resonance Imaging (MRI) Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Open MRI Systems
Closed MRI Systems
Segment by Application
Hospital
Physical Examination Center
Other
The Magnetic Resonance Imaging (MRI) Systems market is analysed and market size information is provided by regions (countries). Segment by Application, the Magnetic Resonance Imaging (MRI) Systems market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Hitachi
Siemens Healthineers
Canon Medical Systems
GE Healthcare
Philips
Aspect Imaging
Bruker
Aurora Imaging Technology
Esaote
Fonar
Neusoft Medical Systems
Shenzhen Mindray Bio-Medical Electronics
In 2017, Asia Pacific is estimated to account for the largest share of the MRI systems market, followed by Europe.
Market Analysis and Insights: Global Magnetic Resonance Imaging (MRI) Systems Market
The global Magnetic Resonance Imaging (MRI) Systems market was valued at US$ 4957.7 in 2020 and will reach US$ 5954.3 million by the end of 2027, growing at a CAGR of 3.1% during 2022-2027.
Global Magnetic Resonance Imaging (MRI) Systems Scope and Market Size
The global Magnetic Resonance Imaging (MRI) Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Magnetic Resonance Imaging (MRI) Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Open MRI Systems
Closed MRI Systems
Segment by Application
Hospital
Physical Examination Center
Other
The Magnetic Resonance Imaging (MRI) Systems market is analysed and market size information is provided by regions (countries). Segment by Application, the Magnetic Resonance Imaging (MRI) Systems market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Hitachi
Siemens Healthineers
Canon Medical Systems
GE Healthcare
Philips
Aspect Imaging
Bruker
Aurora Imaging Technology
Esaote
Fonar
Neusoft Medical Systems
Shenzhen Mindray Bio-Medical Electronics
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
QYR-17504941
04-Mar-2021
132
04-Mar-2021
132
License